Advertisement|Remove ads.

Shares of SRx Health Solutions, Inc. (SRXH) slid 4% in premarket trading on Wednesday after a new prospectus revealed plans to issue up to 418 million shares as part of its merger with EMJ Crypto Technologies, raising dilution concerns as the company pushes deeper into its AI-powered digital-asset pivot.
On Tuesday, SRXH stock posted its second straight session of gains after closing nearly 1% higher at $0.136.
The prospectus relates to stock issuance tied to SRx Health’s proposed acquisition of EMJ Crypto Technologies and CCC Crypto Corp, along with associated intellectual property assets, including AI tools to predict outcomes from large datasets. The issuance could increase the number of outstanding shares by over 20%, the filing said.
The filing covers up to 418.3 million shares that may be issued through a combination of transaction consideration shares, exchangeable shares, and pre-funded warrants linked to the acquisition structure.
The deal comes amid SRx Health’s transformation from a pet-wellness-focused business to a digital-asset treasury platform driven by AI and quantitative models.
The company announced the definitive agreement to acquire EMJ Crypto Technologies in December as part of that strategy shift. Upon completion of the deal, EMJ Capital founder Eric Jackson is expected to become chairman and CEO of the combined company.
The acquisition also includes intellectual property assets, such as an algorithm designed to outperform Bitcoin and Ethereum by leveraging AI-driven analysis of trading volatility.
SRx Health said its hedging pool generated a 5.69% return in March using the EMJX AI engine, compared with a 5% decline in the S&P 500 over the same period. The company added that its board is “strongly considering” introducing a quarterly dividend policy based on a percentage of profits generated from its investment portfolio.
In February, SRx Health authorized $18 million to deploy a “Gen2” treasury model designed to expand beyond single-asset digital strategies. The company reduced short exposure to Bitcoin and Ethereum to near zero across its $18 million cryptocurrency portfolio based on signals from internally developed models, while maintaining allocations to assets such as Solana and gold as part of its volatility-management framework.
SRx Health has also said it intends to allocate up to 10% of future cash flows to cryptocurrencies and precious metals as the EMJ Crypto deal nears completion.
On Stocktwits, retail sentiment for SRXH has remained in the ‘bullish’ and ‘extremely bullish’ zones over the past three months amid ‘high’ 24-hour message volumes.

One user said, “We’re on our way! Be strong! EMJX. Don’t get scared just as the fun begins.”
Another user said, “s4 Filed yesterday Merger intact should see a nice move Bottom penny. “
SRXH stock has plunged 93% over the past year.
For updates and corrections, email newsroom[at]stocktwits[dot]com.